These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 33838040)
1. Modifiable lifestyle risk factors and C-reactive protein in patients with coronary artery disease: Implications for an anti-inflammatory treatment target population. Blaum C; Brunner FJ; Kröger F; Braetz J; Lorenz T; Goßling A; Ojeda F; Koester L; Karakas M; Zeller T; Westermann D; Schnabel R; Blankenberg S; Seiffert M; Waldeyer C Eur J Prev Cardiol; 2021 Apr; 28(2):152–158. PubMed ID: 33838040 [TBL] [Abstract][Full Text] [Related]
2. Adherence to Mediterranean diet, high-sensitive C-reactive protein, and severity of coronary artery disease: Contemporary data from the INTERCATH cohort. Waldeyer C; Brunner FJ; Braetz J; Ruebsamen N; Zyriax BC; Blaum C; Kroeger F; Kohsiack R; Schrage B; Sinning C; Becher PM; Karakas M; Zeller T; Westermann D; Sydow K; Blankenberg S; Seiffert M; Schnabel RB Atherosclerosis; 2018 Aug; 275():256-261. PubMed ID: 29980052 [TBL] [Abstract][Full Text] [Related]
3. The clinical role of combined serum C1q and hsCRP in predicting coronary artery disease. Jia Y; Wen W; Yang Y; Huang M; Ning Y; Jiao X; Liu S; Qin Y; Zhang M Clin Biochem; 2021 Jul; 93():50-58. PubMed ID: 33861985 [TBL] [Abstract][Full Text] [Related]
4. Inflammatory burden, lifestyle and atherosclerotic cardiovascular disease: insights from a population based cohort study. Bay B; Blaum C; Kellner C; Bei der Kellen R; Ojeda F; Waibel J; Arnold N; Behrendt CA; Rimmele DL; Thomalla G; Twerenbold R; Blankenberg S; Zyriax B; Brunner FJ; Waldeyer C Sci Rep; 2023 Dec; 13(1):21761. PubMed ID: 38066176 [TBL] [Abstract][Full Text] [Related]
5. Residual inflammatory risk in coronary heart disease: incidence of elevated high-sensitive CRP in a real-world cohort. Peikert A; Kaier K; Merz J; Manhart L; Schäfer I; Hilgendorf I; Hehn P; Wolf D; Willecke F; Sheng X; Clemens A; Zehender M; von Zur Mühlen C; Bode C; Zirlik A; Stachon P Clin Res Cardiol; 2020 Mar; 109(3):315-323. PubMed ID: 31325043 [TBL] [Abstract][Full Text] [Related]
6. Serum calcium and magnesium were inversely associated with high sensitivity C-reactive protein in Chinese adults with coronary artery disease. Dong H; Hu P; Wang J; Lu N Curr Med Res Opin; 2023 Apr; 39(4):497-503. PubMed ID: 36912027 [TBL] [Abstract][Full Text] [Related]
7. Increased serum YKL-40 and C-reactive protein levels are associated with angiographic lesion progression in patients with coronary artery disease. Zheng JL; Lu L; Hu J; Zhang RY; Zhang Q; Chen QJ; Shen WF Atherosclerosis; 2010 Jun; 210(2):590-5. PubMed ID: 20056225 [TBL] [Abstract][Full Text] [Related]
8. Association of C-reactive protein with the presence and extent of angiographically verified coronary artery disease. Memon L; Spasojević-Kalimanovska V; Bogavac-Stanojević N; Kalimanovska-Ostrić D; Jelić-Ivanović Z; Spasić S; Topić A Tohoku J Exp Med; 2006 Jul; 209(3):197-206. PubMed ID: 16778366 [TBL] [Abstract][Full Text] [Related]
9. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study. Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J; Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589 [TBL] [Abstract][Full Text] [Related]
10. Inflammatory and Cholesterol Risk in the FOURIER Trial. Bohula EA; Giugliano RP; Leiter LA; Verma S; Park JG; Sever PS; Lira Pineda A; Honarpour N; Wang H; Murphy SA; Keech A; Pedersen TR; Sabatine MS Circulation; 2018 Jul; 138(2):131-140. PubMed ID: 29530884 [TBL] [Abstract][Full Text] [Related]
11. Body Mass Index, High-Sensitivity C-Reactive Protein and Mortality in Chinese with Coronary Artery Disease. Ding D; Wang M; Su D; Hong C; Li X; Yang Y; Zhang Y; Hu G; Ling W PLoS One; 2015; 10(8):e0135713. PubMed ID: 26280165 [TBL] [Abstract][Full Text] [Related]
12. Level of high-sensitivity C-reactive protein in Saudi patients with chronic stable coronary artery disease. Habib SS J Ayub Med Coll Abbottabad; 2008; 20(2):3-6. PubMed ID: 19385446 [TBL] [Abstract][Full Text] [Related]
13. Association of C-reactive protein with body fat, diabetes and coronary artery disease in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-6). Mohan V; Deepa R; Velmurugan K; Premalatha G Diabet Med; 2005 Jul; 22(7):863-70. PubMed ID: 15975100 [TBL] [Abstract][Full Text] [Related]
14. Clinical and prognostic implications of C-reactive protein levels in myocardial infarction with nonobstructive coronary arteries. Eggers KM; Baron T; Hjort M; Nordenskjöld AM; Tornvall P; Lindahl B Clin Cardiol; 2021 Jul; 44(7):1019-1027. PubMed ID: 34032303 [TBL] [Abstract][Full Text] [Related]
15. Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease. Rasouli M; Kiasari AM Clin Biochem; 2006 Oct; 39(10):971-7. PubMed ID: 16963013 [TBL] [Abstract][Full Text] [Related]
16. Serum high-sensitivity C-reactive protein and lipoprotein(a) levels: a comparison between diabetic and non-diabetic patients with coronary artery disease. Shahid HS; Kurdi MI; Zohair AA Med J Malaysia; 2011 Jun; 66(2):113-6. PubMed ID: 22106689 [TBL] [Abstract][Full Text] [Related]
17. Significance of inflammatory markers in diabetic patients with stable coronary artery disease. Lee HJ; Her SH; Im YS; Won KY; Yoo SH; Kim DB; Shin DI; Kim PJ; Seung KB; Kim JH; Kim KY Korean J Intern Med; 2009 Sep; 24(3):212-9. PubMed ID: 19721857 [TBL] [Abstract][Full Text] [Related]